It was found that vascular endothelial growth factor (VEGF) levels were significantly higher in patients with SCLC than in the healthy population (6), suggesting that anti-angiogenic therapy may be effective in SCLC. The gene discussed is VEGFA; the disease is small cell lung carcinoma.